Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations

Journal of Bone and Mineral Research

Volumn 15, Issue 3, 2000, Pages 442-450

  Bernard, Mark A ^a   Hogue, Deborah A ^a   Cole, William G ^b   Sanford, Tiffany ^a   Snuggs, Mark B ^a   Montufar Solis, Dina ^c   Duke, P Jackie ^c   Carson, Daniel D ^d   Scott, Allison ^e   Van Winkle, W Barry ^a   Hecht, Jacqueline T ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TEXAS DENTAL BRANCH AT HOUSTON   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

^e Shriners Hospital for Children   (United States)

Author keywords

Cytoskeleton, actin; Exostosis chondrocyte; EXT1 EXT2 genes; Hereditary multiple exostoses

Indexed keywords

ALPHA ACTININ; BETA ACTIN;

ARTICLE; CARTILAGE CELL; CHONDROSARCOMA; CYTOSKELETON; EXOSTOSIS; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0034050894     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.3.442     Document Type: Article

References (39)

1. Ahn J, Ludecke HJ, Lindow S, Horton WA, Lee B, Wagner MJ, Horsthemke B, Wells DE 1995 Cloning of the putative tumor suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet 11:137-143.
2. Stickens D, Clines G, Burbee D, Ramos P, Thomas S, Hogue D, Hecht JT, Lovett M, Evans GA 1996 The EXT2 multiple exostoses gene defines a family of putative tumour suppressor gene. Nat Genet 14:25-32.
3. Wuyts W, Van Hul W, Wauters J, Nemtsova M, Reyniers E, Van Hul EV, De Boulle K, de Vries BB, Hendrickx J, Herrygers I, Bossuyt P, Balemans W, Fransen E, Vits L, Coucke P, Nowak NJ, Shows TB, Mallet L, van den Ouweland AM, McGaughran J, Halley DJ, Willems PJ 1996 Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet 5:1547-1557.
4. Wuyts W, Van Hul W, Hendrickx J, Speleman F, Wauters J, De Boulle K, Van Roy N, Van Agtmael T, Bossuyt P, Willems PJ 1997 Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur J Hum Genet 5:382-389.
5. Wise CA, Clines GA, Massa H, Trask BJ, Lovett M 1997 Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res 7:10-16.
6. Van Hul W, Wuyts W, Hendrickx J, Speleman F, Wauters J, De Boulle K, Van Roy N, Bossuyt P, Willems PJ 1998 Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics 47:230-237.
7. Horton WA 1990 Abnormalities of Bone Structure, Principles and Practices of Medical Genetics, 2nd ed. Churchill Livingstone, London, pp. 953-966.
8. Schmale GA, Conrad EU, Raskind WH 1994 The natural history of hereditary multiple exostoses. J Bone Joint Surg Am 76:986-992.
9. Hennekam RCM 1991 Hereditary multiple exostoses. J Med Genet 28:262-266.
10. Wicklund CL, Pauli RM, Johnston D, Hecht JT 1995 Natural history study of hereditary multiple exostoses. Am J Med Genet 55:43-46.
11. Hecht JT, Hogue D, Wang Y, Blanton SH, Wagner M, Strong LC, Raskind W, Hansen MF, Wells D 1997 Hereditary multiple exosloses (EXT): Mutational studies of familial EXT1 cases and EXT-associated malignancies. Am J Hum Genet 60:80-86.
12. Raskind WH, Conrad EU, Chansky H, Matsushita M 1995 Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet 56:1132-1139.
13. Bellaiche Y, The I, Perrimon N 1998 Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT1 and is needed for Hh diffusion. Nature 394:85-88.
14. McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, Dyer AP, Tufaro F 1998 The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet 19:158-161.
15. Lin X, Gan L, Klein WH, Wells D 1998 Expression and functional analysis of mouse EXT1, a homolog of the human multiple exostoses type 1 gene. Biochem Biophys Res Commun 248:738-743.
16. Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K 1998 The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem 273:26265-26268.
17. French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, Carson DD 1999 Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol 145:1103-1115.
18. Hecht JT, Montufar-Solis D, Decker G, Lawler J, Daniels K, Duke PJ 1998 Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes. Matrix Biol 17:625-633.
19. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Strahl K 1998 Analysis of proteins. In: Current Protocols in Molecular Biology. John Wiley & Sons, Inc., New York, NY, U.S.A., pp. 10.1A-10.6.
20. Van Winkle WB, Snuggs M, Miller JC, Buja LM 1994 Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonemal. Cell Motil Cytoskeleton 28:119-134.
21. Povysil C, Tomanova R, Matejovsky Z 1997 Muscle-specific actin expression in chondroblastomas. Hum Pathol 28:316-320.
22. Dervan PA, O'Loughlin J, Hurson BJ 1988 Dedifferentiated chondrosarcoma with muscle and cytokeratin differentiation in the anaplastic component. Histopathology 12:517-526.
23. Lamovec J, Zidar A, Bracko M, Golouh R 1994 Primary bone sarcoma with rhabdomyosarcomatous component. Pathol Res Pract 190:51-60.
24. Reith JD, Bauer TW, Fischler DF, Joyce MJ, Marks KE 1996 Dedifferentiated chondrosarcoma with rhabdomyosarcomatous differentiation. Am J Surg Pathol 20:293-298.
25. Jockusch BM, Bubeck P, Giehl K, Kroemker M, Moschner J, Rothkegel M, Rüdiger M, Schlüter K, Stanke G, Winkler J 1995 The molecular architecture of focal adhesions. Annu Rev Cell Dev Biol 11:379-416.
26. Sanger JW, Sanger JM, Jockusch BM 1983 Differences in the stress fibers between fibroblasts and epithelial cells. J Cell Biol 96:961-969.
27. Kreis TE, Birchmeier W 1980 Stress fiber sarcomeres of fibroblasts are contractile. Cell 22:555-561.
28. McGough A, Pope B, Chiu W, Weeds A 1997 Cofilin changes the twist of F-actin: Implications for actin filament dynamics and cellular function. J Cell Biol 138:771-781.
29. Otto JJ 1994 Actin-bundling proteins. Curr Opin Cell Biol 6:105-109.
30. Jennekens FG, Roord JJ, Veldman H, Willemse J, Jockusch BM 1983 Congenital nemaline myopathy. I. Defective organization of alpha-actinin is restricted to muscle. Muscle Nerve 6:61-68.
31. Bernfield M, Hooper KC 1991 Possible regulation of FGF activity by syndecan, an integral membrane heparan sulfate proteoglycan. Ann N YAcad Sci 638:182-194.
32. Steinfeld R, Van Den Berghe H, David G 1996 Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 133:405-416.
33. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ 1996 Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622.
34. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM 1996 PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666.
35. Carey DJ, Stahl RC, Tucker B, Bendt KA, Cizmeci-Smith G 1994 Aggregation-induced association of syndecan-1 with microfilaments mediated by the cytoplasmic domain. Exp Cell Res 214:12-21.
36. Woods A, Couchman JR 1994 Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell 5:183-192.
37. Esko JD, Rostand KS, Weinke JL 1988 Tumor formation dependent on proteoglycan biosynthesis. Science 241:1092-1096.
38. Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M, David G 1997 Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer 74:335-345.
39. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M 1995 Hereditary multiple exostosis and chondrosarcoma: Linkage to chromosome 11 and loss of heterozygosity for EXT-linked markers on chromosomes 11 and 8. Am J Hum Genet 56:1125-1131.